146 related articles for article (PubMed ID: 8547588)
1. beta-Amyloid peptide-derived, oxygen-dependent free radicals inhibit glutamate uptake in cultured astrocytes: implications for Alzheimer's disease.
Harris ME; Carney JM; Cole PS; Hensley K; Howard BJ; Martin L; Bummer P; Wang Y; Pedigo NW; Butterfield DA
Neuroreport; 1995 Oct; 6(14):1875-9. PubMed ID: 8547588
[TBL] [Abstract][Full Text] [Related]
2. Amyloid beta peptide (25-35) inhibits Na+-dependent glutamate uptake in rat hippocampal astrocyte cultures.
Harris ME; Wang Y; Pedigo NW; Hensley K; Butterfield DA; Carney JM
J Neurochem; 1996 Jul; 67(1):277-86. PubMed ID: 8667003
[TBL] [Abstract][Full Text] [Related]
3. The inhibitory effects of beta-amyloid on glutamate and glucose uptakes by cultured astrocytes.
Parpura-Gill A; Beitz D; Uemura E
Brain Res; 1997 Apr; 754(1-2):65-71. PubMed ID: 9134960
[TBL] [Abstract][Full Text] [Related]
4. Amyloid beta-peptide inhibits Na+-dependent glutamate uptake.
Lauderback CM; Harris-White ME; Wang Y; Pedigo NW; Carney JM; Butterfield DA
Life Sci; 1999; 65(18-19):1977-81. PubMed ID: 10576449
[TBL] [Abstract][Full Text] [Related]
5. Role of glycine-33 and methionine-35 in Alzheimer's amyloid beta-peptide 1-42-associated oxidative stress and neurotoxicity.
Kanski J; Varadarajan S; Aksenova M; Butterfield DA
Biochim Biophys Acta; 2002 Mar; 1586(2):190-8. PubMed ID: 11959460
[TBL] [Abstract][Full Text] [Related]
6. Role of spermine in amyloid beta-peptide-associated free radical-induced neurotoxicity.
Yatin SM; Yatin M; Varadarajan S; Ain KB; Butterfield DA
J Neurosci Res; 2001 Mar; 63(5):395-401. PubMed ID: 11223914
[TBL] [Abstract][Full Text] [Related]
7. Beta-amyloid-induced changes in cultured astrocytes parallel reactive astrocytosis associated with senile plaques in Alzheimer's disease.
Pike CJ; Cummings BJ; Monzavi R; Cotman CW
Neuroscience; 1994 Nov; 63(2):517-31. PubMed ID: 7891862
[TBL] [Abstract][Full Text] [Related]
8. Methionine residue 35 is important in amyloid beta-peptide-associated free radical oxidative stress.
Varadarajan S; Yatin S; Kanski J; Jahanshahi F; Butterfield DA
Brain Res Bull; 1999 Sep; 50(2):133-41. PubMed ID: 10535332
[TBL] [Abstract][Full Text] [Related]
9. The antioxidant vitamin E modulates amyloid beta-peptide-induced creatine kinase activity inhibition and increased protein oxidation: implications for the free radical hypothesis of Alzheimer's disease.
Yatin SM; Aksenov M; Butterfield DA
Neurochem Res; 1999 Mar; 24(3):427-35. PubMed ID: 10215518
[TBL] [Abstract][Full Text] [Related]
10. Direct evidence of oxidative injury produced by the Alzheimer's beta-amyloid peptide (1-40) in cultured hippocampal neurons.
Harris ME; Hensley K; Butterfield DA; Leedle RA; Carney JM
Exp Neurol; 1995 Feb; 131(2):193-202. PubMed ID: 7895820
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo oxidative stress associated with Alzheimer's amyloid beta-peptide (1-42).
Yatin SM; Varadarajan S; Link CD; Butterfield DA
Neurobiol Aging; 1999; 20(3):325-30; discussion 339-42. PubMed ID: 10588580
[TBL] [Abstract][Full Text] [Related]
12. Neurodegeneration mediated by glutamate and beta-amyloid peptide: a comparison and possible interaction.
Gray CW; Patel AJ
Brain Res; 1995 Sep; 691(1-2):169-79. PubMed ID: 8590049
[TBL] [Abstract][Full Text] [Related]
13. Amyloid beta protein enhances the clearance of extracellular L-glutamate by cultured rat cortical astrocytes.
Abe K; Misawa M
Neurosci Res; 2003 Jan; 45(1):25-31. PubMed ID: 12507721
[TBL] [Abstract][Full Text] [Related]
14. A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease.
Hensley K; Carney JM; Mattson MP; Aksenova M; Harris M; Wu JF; Floyd RA; Butterfield DA
Proc Natl Acad Sci U S A; 1994 Apr; 91(8):3270-4. PubMed ID: 8159737
[TBL] [Abstract][Full Text] [Related]
15. A beta (25-35) peptide displays H2O2-like reactivity towards aqueous Fe2+, nitroxide spin probes, and synaptosomal membrane proteins.
Butterfield DA; Martin L; Carney JM; Hensley K
Life Sci; 1996; 58(3):217-28. PubMed ID: 9499162
[TBL] [Abstract][Full Text] [Related]
16. [Effect of beta-amyloid peptides on alpha-7 nicotinic receptor status in astrocytes and neurons, and its relationship to pathogenesis of Alzheimer's disease].
Xiao Y; Shan KR; Guan ZZ
Zhonghua Bing Li Xue Za Zhi; 2006 Aug; 35(8):462-6. PubMed ID: 17069698
[TBL] [Abstract][Full Text] [Related]
17. Temporal relations among amyloid beta-peptide-induced free-radical oxidative stress, neuronal toxicity, and neuronal defensive responses.
Yatin SM; Aksenova M; Aksenov M; Markesbery WR; Aulick T; Butterfield DA
J Mol Neurosci; 1998 Dec; 11(3):183-97. PubMed ID: 10344789
[TBL] [Abstract][Full Text] [Related]
18. Increased glucose metabolism and impaired glutamate transport in human astrocytes are potential early triggers of abnormal extracellular glutamate accumulation in hiPSC-derived models of Alzheimer's disease.
Salcedo C; Pozo Garcia V; García-Adán B; Ameen AO; Gegelashvili G; Waagepetersen HS; Freude KK; Aldana BI
J Neurochem; 2024 May; 168(5):822-840. PubMed ID: 38063257
[TBL] [Abstract][Full Text] [Related]
19. Inhibitors of free radical formation fail to attenuate direct beta-amyloid25-35 peptide-mediated neurotoxicity in rat hippocampal cultures.
Lockhart BP; Benicourt C; Junien JL; Privat A
J Neurosci Res; 1994 Nov; 39(4):494-505. PubMed ID: 7533847
[TBL] [Abstract][Full Text] [Related]
20. Fibronectin modulation by A beta amyloid peptide (25-35) in cultured astrocytes of newborn rat cortex.
Moreno-Flores MT; Martín-Aparicio E; Salinero O; Wandosell F
Neurosci Lett; 2001 Nov; 314(1-2):87-91. PubMed ID: 11698153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
